Updated results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group for Cancer Care Evaluation study of adjuvant treatment in breast cancer 01 (SITAM 01)
- Resource Type
- Authors
- Antonio Nicolucci; Miriam Valentini; Maurizio Belfiglio; Fabio Pellegrini; Michele Sacco
- Source
- Journal of Clinical Oncology. 23:528-528
- Subject
- Gynecology
Oncology
Cancer Research
medicine.medical_specialty
Adjuvant tamoxifen
business.industry
medicine.medical_treatment
Cancer
medicine.disease
law.invention
Breast cancer
Randomized controlled trial
law
Internal medicine
medicine
Overall survival
business
Adjuvant
Clin oncol
Early breast cancer
- Language
- ISSN
- 1527-7755
0732-183X
528 Background: The study results in terms of disease-free survival (DFS) were already published (J Clin Oncol, 2003;21:2276–81). This is an update of the data relative to overall survival (OS) aft...